Physician profile
Eric Chen
NPI 1881076156
$2,010.20
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,857 · 2022: $115 · 2024: $38.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $412.56 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $330.46 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $224.61 | 2019 | |
| Janssen Biotech, INC. | $125.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $119.68 | 2019 | |
| Celgene Corporation | $117.91 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $115.33 | 2019 | |
| Stryker Corporation | $114.72 | 2022 | |
| Astellas Pharma US INC | $109.32 | 2019 | |
| Merck Sharp & Dohme LLC | $102.34 | 2019 | |
| Kci USA, INC. | $100.04 | 2019 | |
| Jazz Pharmaceuticals INC. | $100.00 | 2019 | |
| Alkermes, INC. | $38.23 | 2024 | Aristada, Lybalvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.